Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?

BACKGROUND: A history of spontaneous preterm birth (sPTB) is a significant risk factor for recurrence. Intra-muscular-7α-hydroxyprogesterone caproate (17P) has been the preventive treatment of choice until the recent “Prolong study” that reported no benefit. OBJECTIVE: To determine the benefit of (1...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Gal, Shavit, Maya, Miller, Netanella, Moran, Rimon, Yagur, Yael, Weitzner, Omer, Ovadia, Michal, Schreiber, Hanoch, Shechter-Maor, Gil, Biron-Shental, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098016/
https://www.ncbi.nlm.nih.gov/pubmed/35551554
http://dx.doi.org/10.1371/journal.pone.0268397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098016/
https://www.ncbi.nlm.nih.gov/pubmed/35551554
http://dx.doi.org/10.1371/journal.pone.0268397

Ejemplares similares